{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T23:38:51Z","timestamp":1793662731916,"version":"4.5.1"},"reference-count":222,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,3,16]],"date-time":"2017-03-16T00:00:00Z","timestamp":1489622400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Clin Dermatol"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1007\/s40257-017-0269-x","type":"journal-article","created":{"date-parts":[[2017,3,16]],"date-time":"2017-03-16T13:21:31Z","timestamp":1489670491000},"page":"491-512","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":123,"title":["Morphea and Eosinophilic Fasciitis: An Update"],"prefix":"10.1007","volume":"18","author":[{"given":"Jorre S.","family":"Mertens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marieke M. B.","family":"Seyger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rogier M.","family":"Thurlings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy R. D. J.","family":"Radstake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elke M. G. J.","family":"de Jong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,16]]},"reference":[{"issue":"3","key":"269_CR1","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.jaad.2008.05.005","volume":"59","author":"S Christen-Zaech","year":"2008","unstructured":"Christen-Zaech S, Hakim MD, Afsar FS, Paller AS. Pediatric morphea (localized scleroderma): review of 136 patients. J Am Acad Dermatol. 2008;59(3):385\u201396. doi: 10.1016\/j.jaad.2008.05.005 .","journal-title":"J Am Acad Dermatol"},{"issue":"9","key":"269_CR2","first-page":"318","volume":"26","author":"AM Nelson","year":"1996","unstructured":"Nelson AM. Localized scleroderma including morphea, linear scleroderma, and eosinophilic fasciitis. Curr Probl Pediatr. 1996;26(9):318\u201324.","journal-title":"Curr Probl Pediatr"},{"issue":"5","key":"269_CR3","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1111\/bjd.13572","volume":"172","author":"NK Klimas","year":"2015","unstructured":"Klimas NK, Shedd AD, Bernstein IH, Jacobe H. Health-related quality of life in morphoea. Br J Dermatol. 2015;172(5):1329\u201337. doi: 10.1111\/bjd.13572 .","journal-title":"Br J Dermatol"},{"issue":"3","key":"269_CR4","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.jaad.2015.09.069","volume":"74","author":"DR Mazori","year":"2016","unstructured":"Mazori DR, Wright NA, Patel M, Liu SW, Ramachandran SM, Franks AG Jr, et al. Characteristics and treatment of adult-onset linear morphea: a retrospective cohort study of 61 patients at 3 tertiary care centers. J Am Acad Dermatol. 2016;74(3):577\u20139. doi: 10.1016\/j.jaad.2015.09.069 .","journal-title":"J Am Acad Dermatol"},{"issue":"9","key":"269_CR5","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.1002\/art.21264","volume":"52","author":"F Zulian","year":"2005","unstructured":"Zulian F, Vallongo C, Woo P, Russo R, Ruperto N, Harper J, et al. Localized scleroderma in childhood is not just a skin disease. Arthritis Rheum. 2005;52(9):2873\u201381. doi: 10.1002\/art.21264 .","journal-title":"Arthritis Rheum"},{"issue":"1","key":"269_CR6","first-page":"73","volume":"24","author":"LS Peterson","year":"1997","unstructured":"Peterson LS, Nelson AM, Su WP, Mason T, O\u2019Fallon WM, Gabriel SE. The epidemiology of morphea (localized scleroderma) in Olmsted County 1960\u20131993. J Rheumatol. 1997;24(1):73\u201380.","journal-title":"J Rheumatol"},{"issue":"4","key":"269_CR7","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1093\/rheumatology\/27.4.286","volume":"27","author":"A Silman","year":"1988","unstructured":"Silman A, Jannini S, Symmons D, Bacon P. An epidemiological study of scleroderma in the West Midlands. Br J Rheumatol. 1988;27(4):286\u201390.","journal-title":"Br J Rheumatol"},{"issue":"2","key":"269_CR8","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1002\/acr.20070","volume":"62","author":"AL Herrick","year":"2010","unstructured":"Herrick AL, Ennis H, Bhushan M, Silman AJ, Baildam EM. Incidence of childhood linear scleroderma and systemic sclerosis in the UK and Ireland. Arthritis Care Res. 2010;62(2):213\u20138. doi: 10.1002\/acr.20070 .","journal-title":"Arthritis Care Res"},{"issue":"6","key":"269_CR9","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1016\/j.jaad.2012.04.003","volume":"67","author":"A Kreuter","year":"2012","unstructured":"Kreuter A, Wischnewski J, Terras S, Altmeyer P, Stucker M, Gambichler T. Coexistence of lichen sclerosus and morphea: a retrospective analysis of 472 patients with localized scleroderma from a German tertiary referral center. J Am Acad Dermatol. 2012;67(6):1157\u201362. doi: 10.1016\/j.jaad.2012.04.003 .","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"269_CR10","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1111\/bjd.13514","volume":"172","author":"JS Mertens","year":"2015","unstructured":"Mertens JS, Seyger MM, Kievit W, Hoppenreijs EP, Jansen TL, van de Kerkhof PC, et al. Disease recurrence in localized scleroderma: a retrospective analysis of 344 patients with paediatric- or adult-onset disease. Br J Dermatol. 2015;172(3):722\u20138. doi: 10.1111\/bjd.13514 .","journal-title":"Br J Dermatol"},{"key":"269_CR11","doi-asserted-by":"publisher","unstructured":"Zulian F, Athreya BH, Laxer R, Nelson AM, Feitosa de Oliveira SK, Punaro MG, et al. Juvenile localized scleroderma: clinical and epidemiological features in 750 children. An international study. Rheumatology (Oxford, England) 2006;45(5):614\u201320. doi: 10.1093\/rheumatology\/kei251 .","DOI":"10.1093\/rheumatology\/kei251"},{"key":"269_CR12","doi-asserted-by":"publisher","unstructured":"Condie D, Grabell D, Jacobe H. Comparison of outcomes in adults with pediatric-onset morphea and those with adult-onset morphea: a cross-sectional study from the morphea in adults and children cohort. Arthritis Rheumatol (Hoboken, NJ) 2014;66(12):3496\u2013504. doi: 10.1002\/art.38853 .","DOI":"10.1002\/art.38853"},{"issue":"5","key":"269_CR13","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1001\/archdermatol.2009.79","volume":"145","author":"JJ Leitenberger","year":"2009","unstructured":"Leitenberger JJ, Cayce RL, Haley RW, Adams-Huet B, Bergstresser PR, Jacobe HT. Distinct autoimmune syndromes in morphea: a review of 245 adult and pediatric cases. Arch Dermatol. 2009;145(5):545\u201350. doi: 10.1001\/archdermatol.2009.79 .","journal-title":"Arch Dermatol"},{"key":"269_CR14","doi-asserted-by":"publisher","unstructured":"Lebeaux D, Frances C, Barete S, Wechsler B, Dubourg O, Renoux J, et al. Eosinophilic fasciitis (Shulman disease): new insights into the therapeutic management from a series of 34 patients. Rheumatology (Oxford, England). 2012;51(3):557\u201361. doi: 10.1093\/rheumatology\/ker366 .","DOI":"10.1093\/rheumatology\/ker366"},{"issue":"4","key":"269_CR15","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0049-0172(88)90008-X","volume":"17","author":"S Lakhanpal","year":"1988","unstructured":"Lakhanpal S, Ginsburg WW, Michet CJ, Doyle JA, Moore SB. Eosinophilic fasciitis: clinical spectrum and therapeutic response in 52 cases. Semin Arthritis Rheum. 1988;17(4):221\u201331.","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"269_CR16","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1001\/jamadermatol.2015.3648","volume":"152","author":"NA Wright","year":"2016","unstructured":"Wright NA, Mazori DR, Patel M, Merola JF, Femia AN, Vleugels RA. Epidemiology and treatment of eosinophilic fasciitis: an analysis of 63 patients from 3 tertiary care centers. JAMA Dermatol. 2016;152(1):97\u20139. doi: 10.1001\/jamadermatol.2015.3648 .","journal-title":"JAMA Dermatol"},{"issue":"3","key":"269_CR17","first-page":"527","volume":"34","author":"R Papa","year":"2016","unstructured":"Papa R, Nozza P, Granata C, Caorsi R, Gattorno M, Martini A, et al. Juvenile eosinophilic fasciitis: three case reports with review of the literature. Clin Exp Rheumatol. 2016;34(3):527\u201330.","journal-title":"Clin Exp Rheumatol"},{"issue":"5 Suppl 1","key":"269_CR18","doi-asserted-by":"publisher","first-page":"S72","DOI":"10.1016\/j.jaad.2007.05.014","volume":"58","author":"AG Ortega-Loayza","year":"2008","unstructured":"Ortega-Loayza AG, Merritt BG, Groben PA, Morrell DS. Eosinophilic fasciitis in a female child. J Am Acad Dermatol. 2008;58(5 Suppl 1):S72\u20134. doi: 10.1016\/j.jaad.2007.05.014 .","journal-title":"J Am Acad Dermatol"},{"issue":"9","key":"269_CR19","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1136\/ard.50.9.647","volume":"50","author":"DW Ching","year":"1991","unstructured":"Ching DW, Petrie JP. Childhood eosinophilic fasciitis presenting as inflammatory polyarthritis and associated with selective IgA deficiency. Ann Rheum Dis. 1991;50(9):647\u20138.","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"269_CR20","first-page":"961","volume":"13","author":"HJ Williams","year":"1986","unstructured":"Williams HJ, Ziter FA, Banta CA. Childhood eosinophilic fasciitis\u2014progression to linear scleroderma. J Rheumatol. 1986;13(5):961\u20132.","journal-title":"J Rheumatol"},{"issue":"4","key":"269_CR21","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.berh.2012.08.001","volume":"26","author":"D Lebeaux","year":"2012","unstructured":"Lebeaux D, Sene D. Eosinophilic fasciitis (Shulman disease). Best Pract Res Clin Rheumatol. 2012;26(4):449\u201358. doi: 10.1016\/j.berh.2012.08.001 .","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"6","key":"269_CR22","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1097\/01.bor.0000245727.40630.c3","volume":"18","author":"RM Laxer","year":"2006","unstructured":"Laxer RM, Zulian F. Localized scleroderma. Curr Opin Rheumatol. 2006;18(6):606\u201313. doi: 10.1097\/01.bor.0000245727.40630.c3 .","journal-title":"Curr Opin Rheumatol"},{"issue":"11","key":"269_CR23","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1016\/s0025-6196(11)64442-x","volume":"70","author":"LS Peterson","year":"1995","unstructured":"Peterson LS, Nelson AM, Su WP. Classification of morphea (localized scleroderma). Mayo Clin Proc. 1995;70(11):1068\u201376. doi: 10.1016\/s0025-6196(11)64442-x .","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"269_CR24","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/ddg.12724","volume":"14","author":"A Kreuter","year":"2016","unstructured":"Kreuter A, Krieg T, Worm M, Wenzel J, Moinzadeh P, Kuhn A, et al. German guidelines for the diagnosis and therapy of localized scleroderma. J German Soc Dermatol JDDG. 2016;14(2):199\u2013216. doi: 10.1111\/ddg.12724 .","journal-title":"J German Soc Dermatol JDDG"},{"issue":"2","key":"269_CR25","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1111\/j.1365-2133.2011.10535.x","volume":"166","author":"L Mirsky","year":"2012","unstructured":"Mirsky L, Chakkittakandiyil A, Laxer RM, O\u2019Brien C, Pope E. Relapse after systemic treatment in paediatric morphoea. Br J Dermatol. 2012;166(2):443\u20135. doi: 10.1111\/j.1365-2133.2011.10535.x .","journal-title":"Br J Dermatol"},{"issue":"9","key":"269_CR26","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1001\/archdermatol.2010.239","volume":"146","author":"S Saxton-Daniels","year":"2010","unstructured":"Saxton-Daniels S, Jacobe HT. An evaluation of long-term outcomes in adults with pediatric-onset morphea. Arch Dermatol. 2010;146(9):1044\u20135. doi: 10.1001\/archdermatol.2010.239 .","journal-title":"Arch Dermatol"},{"issue":"6","key":"269_CR27","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1111\/bjd.12606","volume":"169","author":"M Piram","year":"2013","unstructured":"Piram M, McCuaig CC, Saint-Cyr C, Marcoux D, Hatami A, Haddad E, et al. Short- and long-term outcome of linear morphoea in children. Br J Dermatol. 2013;169(6):1265\u201371. doi: 10.1111\/bjd.12606 .","journal-title":"Br J Dermatol"},{"issue":"7","key":"269_CR28","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1002\/art.30264","volume":"63","author":"F Zulian","year":"2011","unstructured":"Zulian F, Martini G, Vallongo C, Vittadello F, Falcini F, Patrizi A, et al. Methotrexate treatment in juvenile localized scleroderma: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 2011;63(7):1998\u20132006. doi: 10.1002\/art.30264 .","journal-title":"Arthritis Rheum"},{"issue":"3","key":"269_CR29","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.jaad.2013.10.018","volume":"70","author":"R Vasquez","year":"2014","unstructured":"Vasquez R, Jabbar A, Khan F, Buethe D, Ahn C, Jacobe H. Recurrence of morphea after successful ultraviolet al phototherapy: a cohort study. J Am Acad Dermatol. 2014;70(3):481\u20138. doi: 10.1016\/j.jaad.2013.10.018 .","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"269_CR30","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1136\/bjo.2007.116038","volume":"91","author":"ME Zannin","year":"2007","unstructured":"Zannin ME, Martini G, Athreya BH, Russo R, Higgins G, Vittadello F, et al. Ocular involvement in children with localised scleroderma: a multi-centre study. Br J Ophthalmol. 2007;91(10):1311\u20134. doi: 10.1136\/bjo.2007.116038 .","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"269_CR31","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3928\/0191-3913-19870101-07","volume":"24","author":"MT Miller","year":"1987","unstructured":"Miller MT, Sloane H, Goldberg MF, Grisolano J, Frenkel M, Mafee MF. Progressive hemifacial atrophy (Parry\u2013Romberg disease). J Pediatr Ophthalmol Strabismus. 1987;24(1):27\u201336.","journal-title":"J Pediatr Ophthalmol Strabismus"},{"issue":"2","key":"269_CR32","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.jaad.2006.10.959","volume":"56","author":"MM Tollefson","year":"2007","unstructured":"Tollefson MM, Witman PM. En coup de sabre morphea and Parry\u2013Romberg syndrome: a retrospective review of 54 patients. J Am Acad Dermatol. 2007;56(2):257\u201363. doi: 10.1016\/j.jaad.2006.10.959 .","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"269_CR33","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1111\/j.1440-1754.2012.02435.x","volume":"48","author":"S Trainito","year":"2012","unstructured":"Trainito S, Favero L, Martini G, Pedersen TK, Favero V, Herlin T, et al. Odontostomatologic involvement in juvenile localised scleroderma of the face. J Paediatr Child Health. 2012;48(7):572\u20136. doi: 10.1111\/j.1440-1754.2012.02435.x .","journal-title":"J Paediatr Child Health"},{"issue":"4","key":"269_CR34","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0901-5027(88)80044-4","volume":"17","author":"AA Talacko","year":"1988","unstructured":"Talacko AA, Reade PC. Hemifacial atrophy and temporomandibular joint pain-dysfunction syndrome. Int J Oral Maxillofac Surg. 1988;17(4):224\u20136.","journal-title":"Int J Oral Maxillofac Surg"},{"issue":"4","key":"269_CR35","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1111\/j.1365-263X.2006.00730.x","volume":"16","author":"S O\u2019Flynn","year":"2006","unstructured":"O\u2019Flynn S, Kinirons M. Parry\u2013Romberg syndrome: a report of the dental findings in a child followed up for 9 years. Int J Paediatr Dent. 2006;16(4):297\u2013301. doi: 10.1111\/j.1365-263X.2006.00730.x .","journal-title":"Int J Paediatr Dent"},{"key":"269_CR36","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13023-015-0250-9","volume":"10","author":"SN Tolkachjov","year":"2015","unstructured":"Tolkachjov SN, Patel NG, Tollefson MM. Progressive hemifacial atrophy: a review. Orphanet J Rare Dis. 2015;10:39. doi: 10.1186\/s13023-015-0250-9 .","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"269_CR37","first-page":"632","volume":"14","author":"KW Huang","year":"1987","unstructured":"Huang KW, Chen XH. Pathology of eosinophilic fasciitis and its relation to polymyositis. Can J Neurol Sci. 1987;14(4):632\u20137.","journal-title":"Can J Neurol Sci"},{"issue":"4","key":"269_CR38","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.diii.2014.06.018","volume":"96","author":"T Kirchgesner","year":"2015","unstructured":"Kirchgesner T, Dallaudiere B, Omoumi P, Malghem J, Vande Berg B, Lecouvet F, et al. Eosinophilic fasciitis: typical abnormalities, variants and differential diagnosis of fasciae abnormalities using MR imaging. Diagn Intervent Imaging. 2015;96(4):341\u20138. doi: 10.1016\/j.diii.2014.06.018 .","journal-title":"Diagn Intervent Imaging."},{"issue":"4","key":"269_CR39","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1111\/j.1365-2230.2005.01753.x","volume":"30","author":"KL Agnew","year":"2005","unstructured":"Agnew KL, Blunt D, Francis ND, Bunker CB. Magnetic resonance imaging in eosinophilic fasciitis. Clin Exp Dermatol. 2005;30(4):435\u20136. doi: 10.1111\/j.1365-2230.2005.01753.x .","journal-title":"Clin Exp Dermatol"},{"issue":"1","key":"269_CR40","doi-asserted-by":"publisher","first-page":"169","DOI":"10.2214\/ajr.184.1.01840169","volume":"184","author":"F Baumann","year":"2005","unstructured":"Baumann F, Bruhlmann P, Andreisek G, Michel BA, Marincek B, Weishaupt D. MRI for diagnosis and monitoring of patients with eosinophilic fasciitis. AJR Am J Roentgenol. 2005;184(1):169\u201374. doi: 10.2214\/ajr.184.1.01840169 .","journal-title":"AJR Am J Roentgenol"},{"issue":"4","key":"269_CR41","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1136\/ard.2007.076844","volume":"67","author":"F Dybowski","year":"2008","unstructured":"Dybowski F, Neuen-Jacob E, Braun J. Eosinophilic fasciitis and myositis: use of imaging modalities for diagnosis and monitoring. Ann Rheum Dis. 2008;67(4):572\u20134. doi: 10.1136\/ard.2007.076844 .","journal-title":"Ann Rheum Dis"},{"key":"269_CR42","doi-asserted-by":"publisher","unstructured":"Mondal S, Goswami RP, Sinha D, Ghosh A. Ultrasound is a useful adjunct in diagnosis of eosinophilic fasciitis. Rheumatology (Oxford, England) 2015;54(11):2041. doi: 10.1093\/rheumatology\/kev290 .","DOI":"10.1093\/rheumatology\/kev290"},{"issue":"6","key":"269_CR43","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.jbspin.2014.07.001","volume":"81","author":"I Marie","year":"2014","unstructured":"Marie I, Sauvetre G. Fluorodeoxyglucose positron emission tomography in eosinophilic fasciitis. Jt Bone Spine Revue Rhum. 2014;81(6):541. doi: 10.1016\/j.jbspin.2014.07.001 .","journal-title":"Jt Bone Spine Revue Rhum"},{"issue":"9","key":"269_CR44","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1097\/rlu.0000000000000260","volume":"39","author":"HJ Kim","year":"2014","unstructured":"Kim HJ, Lee SW, Kim GJ, Lee JH. Usefulness of FDG PET\/CT in the diagnosis of eosinophilic fasciitis. Clin Nucl Med. 2014;39(9):801\u20132. doi: 10.1097\/rlu.0000000000000260 .","journal-title":"Clin Nucl Med"},{"issue":"11","key":"269_CR45","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1093\/qjmed\/hcq218","volume":"104","author":"S Cheriet","year":"2011","unstructured":"Cheriet S, Chastan M, Levesque H, Marie I. Positron emission tomography in the diagnosis of eosinophilic fasciitis. QJM. 2011;104(11):987\u20138. doi: 10.1093\/qjmed\/hcq218 .","journal-title":"QJM"},{"key":"269_CR46","doi-asserted-by":"publisher","unstructured":"Takehara K, Sato S. Localized scleroderma is an autoimmune disorder. Rheumatology (Oxford, England) 2005;44(3):274\u20139. doi: 10.1093\/rheumatology\/keh487 .","DOI":"10.1093\/rheumatology\/keh487"},{"issue":"5","key":"269_CR47","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1097\/BOR.0b013e3283641f61","volume":"25","author":"F Zulian","year":"2013","unstructured":"Zulian F, Cuffaro G, Sperotto F. Scleroderma in children: an update. Curr Opin Rheumatol. 2013;25(5):643\u201350. doi: 10.1097\/BOR.0b013e3283641f61 .","journal-title":"Curr Opin Rheumatol"},{"key":"269_CR48","doi-asserted-by":"publisher","unstructured":"Fett N, Werth VP. Update on morphea: Part I. Epidemiology, clinical presentation, and pathogenesis. J Am Acad Dermatol. 2011;64(2):217\u201328. doi: 10.1016\/j.jaad.2010.05.045 . (quiz 29\u201330).","DOI":"10.1016\/j.jaad.2010.05.045"},{"issue":"19","key":"269_CR49","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1056\/NEJMra0806188","volume":"360","author":"A Gabrielli","year":"2009","unstructured":"Gabrielli A, Avvedimento EV, Krieg T. Scleroderma. N Engl J Med. 2009;360(19):1989\u20132003. doi: 10.1056\/NEJMra0806188 .","journal-title":"N Engl J Med"},{"issue":"3","key":"269_CR50","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.rdc.2015.04.002","volume":"41","author":"EP Stern","year":"2015","unstructured":"Stern EP, Denton CP. The pathogenesis of systemic sclerosis. Rheum Dis Clin N Am. 2015;41(3):367\u201382. doi: 10.1016\/j.rdc.2015.04.002 .","journal-title":"Rheum Dis Clin N Am"},{"issue":"4","key":"269_CR51","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2174\/157339710904140417125010","volume":"9","author":"M Cutolo","year":"2013","unstructured":"Cutolo M, Pizzorni C, Sulli A, Smith V. Early diagnostic and predictive value of capillaroscopy in systemic sclerosis. Curr Rheumatol Rev. 2013;9(4):249\u201353.","journal-title":"Curr Rheumatol Rev."},{"issue":"6","key":"269_CR52","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1111\/j.0303-6987.2004.00203.x","volume":"31","author":"P Helmbold","year":"2004","unstructured":"Helmbold P, Fiedler E, Fischer M, Marsch W. Hyperplasia of dermal microvascular pericytes in scleroderma. J Cutan Pathol. 2004;31(6):431\u201340. doi: 10.1111\/j.0303-6987.2004.00203.x .","journal-title":"J Cutan Pathol"},{"issue":"10","key":"269_CR53","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1001\/jamadermatol.2013.4207","volume":"149","author":"JW Dharamsi","year":"2013","unstructured":"Dharamsi JW, Victor S, Aguwa N, Ahn C, Arnett F, Mayes MD, et al. Morphea in adults and children cohort III: nested case\u2013control study\u2014the clinical significance of autoantibodies in morphea. JAMA Dermatol. 2013;149(10):1159\u201365. doi: 10.1001\/jamadermatol.2013.4207 .","journal-title":"JAMA Dermatol"},{"issue":"12","key":"269_CR54","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.3899\/jrheum.080098","volume":"35","author":"T Arkachaisri","year":"2008","unstructured":"Arkachaisri T, Fertig N, Pino S, Medsger TA Jr. Serum autoantibodies and their clinical associations in patients with childhood- and adult-onset linear scleroderma. A single-center study. J Rheumatol. 2008;35(12):2439\u201344. doi: 10.3899\/jrheum.080098 .","journal-title":"J Rheumatol"},{"issue":"3","key":"269_CR55","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1001\/archderm.1987.01660270088021","volume":"123","author":"V Falanga","year":"1987","unstructured":"Falanga V, Medsger TA Jr, Reichlin M. Antinuclear and anti-single-stranded DNA antibodies in morphea and generalized morphea. Arch Dermatol. 1987;123(3):350\u20133.","journal-title":"Arch Dermatol"},{"issue":"4","key":"269_CR56","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0190-9622(94)70217-9","volume":"31","author":"S Sato","year":"1994","unstructured":"Sato S, Fujimoto M, Ihn H, Kikuchi K, Takehara K. Clinical characteristics associated with antihistone antibodies in patients with localized scleroderma. J Am Acad Dermatol. 1994;31(4):567\u201371.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"269_CR57","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1001\/archderm.121.3.345","volume":"121","author":"V Falanga","year":"1985","unstructured":"Falanga V, Medsger TA, Reichlin M. High titers of antibodies to single-stranded DNA in linear scleroderma. Arch Dermatol. 1985;121(3):345\u20137.","journal-title":"Arch Dermatol"},{"issue":"6","key":"269_CR58","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1111\/j.1365-2133.2004.06256.x","volume":"151","author":"S Sato","year":"2004","unstructured":"Sato S, Kodera M, Hasegawa M, Fujimoto M, Takehara K. Antinucleosome antibody is a major autoantibody in localized scleroderma. Br J Dermatol. 2004;151(6):1182\u20138. doi: 10.1111\/j.1365-2133.2004.06256.x .","journal-title":"Br J Dermatol"},{"issue":"5","key":"269_CR59","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1365-2133.1989.tb01350.x","volume":"120","author":"CI Harrington","year":"1989","unstructured":"Harrington CI, Dunsmore IR. An investigation into the incidence of auto-immune disorders in patients with localized morphoea. Br J Dermatol. 1989;120(5):645\u20138.","journal-title":"Br J Dermatol"},{"key":"269_CR60","doi-asserted-by":"publisher","unstructured":"Jacobe H, Ahn C, Arnett FC, Reveille JD. Major histocompatibility complex class I and class II alleles may confer susceptibility to or protection against morphea: findings from the morphea in adults and children cohort. Arthritis Rheumatol (Hoboken, NJ). 2014;66(11):3170\u20137. doi: 10.1002\/art.38814 .","DOI":"10.1002\/art.38814"},{"issue":"1 Pt 1","key":"269_CR61","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0190-9622(00)90010-0","volume":"42","author":"K Yamane","year":"2000","unstructured":"Yamane K, Ihn H, Kubo M, Yazawa N, Kikuchi K, Soma Y, et al. Increased serum levels of soluble vascular cell adhesion molecule 1 and E-selectin in patients with localized scleroderma. J Am Acad Dermatol. 2000;42(1 Pt 1):64\u20139.","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"269_CR62","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0190-9622(94)70221-7","volume":"31","author":"H Ihn","year":"1994","unstructured":"Ihn H, Fujimoto M, Sato S, Kikuchi K, Igarashi A, Soma Y, et al. Increased levels of circulating intercellular adhesion molecule-1 in patients with localized scleroderma. J Am Acad Dermatol. 1994;31(4):591\u20135.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"269_CR63","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/art.1780350111","volume":"35","author":"BW Needleman","year":"1992","unstructured":"Needleman BW, Wigley FM, Stair RW. Interleukin-1, interleukin-2, interleukin-4, interleukin-6, tumor necrosis factor alpha, and interferon-gamma levels in sera from patients with scleroderma. Arthritis Rheum. 1992;35(1):67\u201372.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"269_CR64","first-page":"328","volume":"24","author":"M Hasegawa","year":"1997","unstructured":"Hasegawa M, Fujimoto M, Kikuchi K, Takehara K. Elevated serum levels of interleukin 4 (IL-4), IL-10, and IL-13 in patients with systemic sclerosis. J Rheumatol. 1997;24(2):328\u201332.","journal-title":"J Rheumatol."},{"issue":"7","key":"269_CR65","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1001\/archderm.1996.03890310088013","volume":"132","author":"V Salmon-Ehr","year":"1996","unstructured":"Salmon-Ehr V, Serpier H, Nawrocki B, Gillery P, Clavel C, Kalis B, et al. Expression of interleukin-4 in scleroderma skin specimens and scleroderma fibroblast cultures. Potential role in fibrosis. Arch Dermatol. 1996;132(7):802\u20136.","journal-title":"Arch Dermatol"},{"issue":"3","key":"269_CR66","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.semarthrit.2015.06.006","volume":"45","author":"KS Torok","year":"2015","unstructured":"Torok KS, Kurzinski K, Kelsey C, Yabes J, Magee K, Vallejo AN, et al. Peripheral blood cytokine and chemokine profiles in juvenile localized scleroderma: T-helper cell-associated cytokine profiles. Semin Arthritis Rheum. 2015;45(3):284\u201393. doi: 10.1016\/j.semarthrit.2015.06.006 .","journal-title":"Semin Arthritis Rheum"},{"issue":"6","key":"269_CR67","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.5114\/aoms.2012.32421","volume":"8","author":"A Danczak-Pazdrowska","year":"2012","unstructured":"Danczak-Pazdrowska A, Kowalczyk M, Szramka-Pawlak B, Gornowicz-Porowska J, Szewczyk A, Silny W, et al. Interleukin-17A and interleukin-23 in morphea. Arch Med Sci. 2012;8(6):1089\u201395. doi: 10.5114\/aoms.2012.32421 .","journal-title":"Arch Med Sci"},{"key":"269_CR68","doi-asserted-by":"crossref","unstructured":"Hasegawa M, Sato S, Nagaoka T, Fujimoto M, Takehara K. Serum levels of tumor necrosis factor and interleukin-13 are elevated in patients with localized scleroderma. Dermatology (Basel, Switzerland) 2003;207(2):141\u20137.","DOI":"10.1159\/000071783"},{"issue":"12","key":"269_CR69","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1038\/nrrheum.2014.137","volume":"10","author":"R Lafyatis","year":"2014","unstructured":"Lafyatis R. Transforming growth factor beta\u2014at the centre of systemic sclerosis. Nat Rev Rheumatol. 2014;10(12):706\u201319. doi: 10.1038\/nrrheum.2014.137 .","journal-title":"Nat Rev Rheumatol"},{"issue":"2","key":"269_CR70","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/art.1780370218","volume":"37","author":"H Higley","year":"1994","unstructured":"Higley H, Persichitte K, Chu S, Waegell W, Vancheeswaran R, Black C. Immunocytochemical localization and serologic detection of transforming growth factor beta 1. Association with type I procollagen and inflammatory cell markers in diffuse and limited systemic sclerosis, morphea, and Raynaud\u2019s phenomenon. Arthritis Rheum. 1994;37(2):278\u201388.","journal-title":"Arthritis Rheum"},{"issue":"3","key":"269_CR71","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1002\/1529-0131(200103)44:3<731::aid-anr124>3.0.co;2-u","volume":"44","author":"M Kubo","year":"2001","unstructured":"Kubo M, Ihn H, Yamane K, Tamaki K. Up-regulated expression of transforming growth factor beta receptors in dermal fibroblasts in skin sections from patients with localized scleroderma. Arthritis Rheum. 2001;44(3):731\u20134. doi: 10.1002\/1529-0131(200103)44:3<731:aid-anr124>3.0.co;2-u .","journal-title":"Arthritis Rheum"},{"key":"269_CR72","doi-asserted-by":"publisher","unstructured":"Fang F, Goncalves Marangoni R, Zhou X, Yang Y, Ye B, Shangguang A, et al. Toll-like receptor 9 signaling is augmented in systemic sclerosis and elicits transforming growth factor beta-dependent fibroblast activation. Arthritis Rheumatol (Hoboken, NJ) 2016;68(8):1989\u20132002. doi: 10.1002\/art.39655 .","DOI":"10.1002\/art.39655"},{"key":"269_CR73","doi-asserted-by":"publisher","unstructured":"Bhattacharyya S, Tamaki Z, Wang W, Hinchcliff M, Hoover P, Getsios S, et al. Fibronectin EDA promotes chronic cutaneous fibrosis through toll-like receptor signaling. Sci Transl Med. 2014;6(232):232ra50. doi: 10.1126\/scitranslmed.3008264 .","DOI":"10.1126\/scitranslmed.3008264"},{"issue":"5","key":"269_CR74","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1056\/NEJMoa1114576","volume":"370","author":"L Bon van","year":"2014","unstructured":"van Bon L, Affandi AJ, Broen J, Christmann RB, Marijnissen RJ, Stawski L, et al. Proteome-wide analysis and CXCL4 as a biomarker in systemic sclerosis. N Engl J Med. 2014;370(5):433\u201343. doi: 10.1056\/NEJMoa1114576 .","journal-title":"N Engl J Med."},{"key":"269_CR75","doi-asserted-by":"publisher","first-page":"11703","DOI":"10.1038\/ncomms11703","volume":"7","author":"S Bhattacharyya","year":"2016","unstructured":"Bhattacharyya S, Wang W, Morales-Nebreda L, Feng G, Wu M, Zhou X, et al. Tenascin-C drives persistence of organ fibrosis. Nat Commun. 2016;7:11703. doi: 10.1038\/ncomms11703 .","journal-title":"Nat Commun."},{"issue":"4","key":"269_CR76","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1002\/1096-9896(2000)9999:9999<::aid-path779>3.0.co;2-8","volume":"193","author":"MM Seyger","year":"2001","unstructured":"Seyger MM, van den Hoogen FH, van Vlijmen-Willems IM, van de Kerkhof PC, de Jong EM. Localized and systemic scleroderma show different histological responses to methotrexate therapy. J Pathol. 2001;193(4):511\u20136. doi: 10.1002\/1096-9896(2000)9999:9999<:aid-path779>3.0.co;2-8 .","journal-title":"J Pathol"},{"issue":"7","key":"269_CR77","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1002\/art.11173","volume":"48","author":"C Feghali-Bostwick","year":"2003","unstructured":"Feghali-Bostwick C, Medsger TA Jr, Wright TM. Analysis of systemic sclerosis in twins reveals low concordance for disease and high concordance for the presence of antinuclear antibodies. Arthritis Rheum. 2003;48(7):1956\u201363. doi: 10.1002\/art.11173 .","journal-title":"Arthritis Rheum"},{"issue":"11","key":"269_CR78","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nrrheum.2014.128","volume":"10","author":"JC Broen","year":"2014","unstructured":"Broen JC, Radstake TR, Rossato M. The role of genetics and epigenetics in the pathogenesis of systemic sclerosis. Nat Rev Rheumatol. 2014;10(11):671\u201381. doi: 10.1038\/nrrheum.2014.128 .","journal-title":"Nat Rev Rheumatol"},{"key":"269_CR79","doi-asserted-by":"publisher","unstructured":"Makino K, Jinnin M, Hirano A, Yamane K, Eto M, Kusano T, et al. The downregulation of microRNA let-7a contributes to the excessive expression of type I collagen in systemic and localized scleroderma. J Immunol. (Baltimore, MD, 1950) 2013;190(8):3905\u201315. doi: 10.4049\/jimmunol.1200822 .","DOI":"10.4049\/jimmunol.1200822"},{"issue":"4","key":"269_CR80","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1684\/ejd.2014.2384","volume":"24","author":"T Makino","year":"2014","unstructured":"Makino T, Jinnin M, Etoh M, Yamane K, Kajihara I, Makino K, et al. Down-regulation of microRNA-196a in the sera and involved skin of localized scleroderma patients. Eur J Dermatol. 2014;24(4):470\u20136. doi: 10.1684\/ejd.2014.2384 .","journal-title":"Eur J Dermatol"},{"key":"269_CR81","doi-asserted-by":"publisher","first-page":"20314","DOI":"10.1038\/srep20314","volume":"6","author":"Q Yan","year":"2016","unstructured":"Yan Q, Chen J, Li W, Bao C, Fu Q. Targeting miR-155 to treat experimental scleroderma. Sci Rep. 2016;6:20314. doi: 10.1038\/srep20314 .","journal-title":"Sci Rep"},{"issue":"3","key":"269_CR82","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.jaad.2014.04.009","volume":"71","author":"D Grabell","year":"2014","unstructured":"Grabell D, Hsieh C, Andrew R, Martires K, Kim A, Vasquez R, et al. The role of skin trauma in the distribution of morphea lesions: a cross-sectional survey of the morphea in adults and children cohort IV. J Am Acad Dermatol. 2014;71(3):493\u20138. doi: 10.1016\/j.jaad.2014.04.009 .","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"269_CR83","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1111\/jdv.12704","volume":"29","author":"M Spalek","year":"2015","unstructured":"Spalek M, Jonska-Gmyrek J, Galecki J. Radiation-induced morphea\u2014a literature review. J Eur Acad Dermatol Venereol JEADV. 2015;29(2):197\u2013202. doi: 10.1111\/jdv.12704 .","journal-title":"J Eur Acad Dermatol Venereol JEADV."},{"issue":"6","key":"269_CR84","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1111\/j.1365-2133.2007.08235.x","volume":"157","author":"K Eisendle","year":"2007","unstructured":"Eisendle K, Grabner T, Zelger B. Morphoea: a manifestation of infection with Borrelia species? Br J Dermatol. 2007;157(6):1189\u201398. doi: 10.1111\/j.1365-2133.2007.08235.x .","journal-title":"Br J Dermatol"},{"issue":"2","key":"269_CR85","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.jaad.2008.09.023","volume":"60","author":"JC Prinz","year":"2009","unstructured":"Prinz JC, Kutasi Z, Weisenseel P, Poto L, Battyani Z, Ruzicka T. \u201cBorrelia-associated early-onset morphea\u201d: a particular type of scleroderma in childhood and adolescence with high titer antinuclear antibodies? Results of a cohort analysis and presentation of three cases. J Am Acad Dermatol. 2009;60(2):248\u201355. doi: 10.1016\/j.jaad.2008.09.023 .","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"269_CR86","first-page":"121","volume":"32","author":"RM Verberkt","year":"2014","unstructured":"Verberkt RM, Janssen M, Wesseling J. A boy with a tight skin: Borrelia-associated early-onset morphea. Clin Exp Rheumatol. 2014;32(1):121\u20132.","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"269_CR87","doi-asserted-by":"publisher","first-page":"383","DOI":"10.4103\/0378-6323.95460","volume":"78","author":"B Miglino","year":"2012","unstructured":"Miglino B, Viana M, Zavattaro E, Bonin S, Valente G, Colombo E. Localized scleroderma unius lateri and Borrelia burgdoferi infection. Indian J Dermatol Venereol Leprol. 2012;78(3):383\u20135. doi: 10.4103\/0378-6323.95460 .","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"3","key":"269_CR88","first-page":"283","volume":"47","author":"F Espinoza-Leon","year":"2006","unstructured":"Espinoza-Leon F, Hassanhi-Hassanhi M, Arocha-Sandoval F, Urbina-Lopez M. Absence of Borrelia burgdorferi antibodies in the sera of Venezuelan patients with localized scleroderma (morphea). Invest Clin. 2006;47(3):283\u20138.","journal-title":"Invest Clin"},{"issue":"4","key":"269_CR89","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1046\/j.1365-2133.2000.03775.x","volume":"143","author":"B Weide","year":"2000","unstructured":"Weide B, Schittek B, Klyscz T, Schuz K, Stark M, Rassner G, et al. Morphoea is neither associated with features of Borrelia burgdorferi infection, nor is this agent detectable in lesional skin by polymerase chain reaction. Br J Dermatol. 2000;143(4):780\u20135.","journal-title":"Br J Dermatol."},{"issue":"9","key":"269_CR90","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1001\/archderm.133.9.1174","volume":"133","author":"MI Colome-Grimmer","year":"1997","unstructured":"Colome-Grimmer MI, Payne DA, Tyring SK, Sanchez RL. Borrelia burgdorferi DNA and Borrelia hermsii DNA are not associated with morphea or lichen sclerosus et atrophicus in the southwestern United States. Arch Dermatol. 1997;133(9):1174.","journal-title":"Arch Dermatol"},{"issue":"4","key":"269_CR91","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2340\/0001555577299304","volume":"77","author":"J Alonso-Llamazares","year":"1997","unstructured":"Alonso-Llamazares J, Persing DH, Anda P, Gibson LE, Rutledge BJ, Iglesias L. No evidence for Borrelia burgdorferi infection in lesions of morphea and lichen sclerosus et atrophicus in Spain. A prospective study and literature review. Acta Dermato Venereol. 1997;77(4):299\u2013304.","journal-title":"Acta Dermato Venereol"},{"issue":"3","key":"269_CR92","first-page":"573","volume":"23","author":"S Akimoto","year":"1996","unstructured":"Akimoto S, Ishikawa O, Miyachi Y. The absence of antibodies against Borrelia burgdorferi in the sera of Japanese patients with localized scleroderma. J Rheumatol. 1996;23(3):573\u20134.","journal-title":"J Rheumatol."},{"issue":"4","key":"269_CR93","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/j.1600-0560.1996.tb01309.x","volume":"23","author":"JR Vito De","year":"1996","unstructured":"De Vito JR, Merogi AJ, Vo T, Boh EE, Fung HK, Freeman SM, et al. Role of Borrelia burgdorferi in the pathogenesis of morphea\/scleroderma and lichen sclerosus et atrophicus: a PCR study of thirty-five cases. J Cutan Pathol. 1996;23(4):350\u20138.","journal-title":"J Cutan Pathol"},{"issue":"4","key":"269_CR94","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/0190-9622(95)91311-4","volume":"33","author":"W Fan","year":"1995","unstructured":"Fan W, Leonardi CL, Penneys NS. Absence of Borrelia burgdorferi in patients with localized scleroderma (morphea). J Am Acad Dermatol. 1995;33(4):682\u20134.","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"269_CR95","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/0190-9622(95)91281-9","volume":"33","author":"WI Dillon","year":"1995","unstructured":"Dillon WI, Saed GM, Fivenson DP. Borrelia burgdorferi DNA is undetectable by polymerase chain reaction in skin lesions of morphea, scleroderma, or lichen sclerosus et atrophicus of patients from North America. J Am Acad Dermatol. 1995;33(4):617\u201320.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"269_CR96","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/1523-1747.ep12613456","volume":"104","author":"R Wienecke","year":"1995","unstructured":"Wienecke R, Schlupen EM, Zochling N, Neubert U, Meurer M, Volkenandt M. No evidence for Borrelia burgdorferi-specific DNA in lesions of localized scleroderma. J Invest Dermatol. 1995;104(1):23\u20136.","journal-title":"J Invest Dermatol"},{"issue":"8","key":"269_CR97","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1111\/ijd.12105","volume":"53","author":"C Gutierrez-Gomez","year":"2014","unstructured":"Gutierrez-Gomez C, Godinez-Hana AL, Garcia-Hernandez M, Suarez-Roa Mde L, Toussaint-Caire S, Vega-Memije E, et al. Lack of IgG antibody seropositivity to Borrelia burgdorferi in patients with Parry\u2013Romberg syndrome and linear morphea en coup de sabre in Mexico. Int J Dermatol. 2014;53(8):947\u201351. doi: 10.1111\/ijd.12105 .","journal-title":"Int J Dermatol"},{"issue":"2","key":"269_CR98","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1684\/ejd.2013.1929","volume":"23","author":"MS Chimenti","year":"2013","unstructured":"Chimenti MS, Teoli M, Di Stefani A, Giunta A, Esposito M, Perricone R. Resolution with rituximab of localized scleroderma occurring during etanercept treatment in a patient with rheumatoid arthritis. Eur J Dermatol EJD. 2013;23(2):273\u20134. doi: 10.1684\/ejd.2013.1929 .","journal-title":"Eur J Dermatol EJD"},{"issue":"1","key":"269_CR99","first-page":"59","volume":"11","author":"FA Stewart","year":"2013","unstructured":"Stewart FA, Gavino AC, Elewski BE. New side effect of TNF-alpha inhibitors: morphea. Skinmed. 2013;11(1):59\u201360.","journal-title":"Skinmed."},{"issue":"4","key":"269_CR100","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1007\/s10165-011-0550-4","volume":"22","author":"J Ramirez","year":"2012","unstructured":"Ramirez J, Hernandez MV, Galve J, Canete JD, Sanmarti R. Morphea associated with the use of adalimumab: a case report and review of the literature. Mod Rheumatol\/Jpn RheumAssoc. 2012;22(4):602\u20134. doi: 10.1007\/s10165-011-0550-4 .","journal-title":"Mod Rheumatol\/Jpn RheumAssoc"},{"issue":"3","key":"269_CR101","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1684\/ejd.2010.0946","volume":"20","author":"C Mattozzi","year":"2010","unstructured":"Mattozzi C, Richetta AG, Cantisani C, Giancristoforo S, D\u2019Epiro S, Gonzalez Serva A, et al. Morphea, an unusual side effect of anti-TNF-alpha treatment. Eur J Dermatol EJD. 2010;20(3):400\u20131. doi: 10.1684\/ejd.2010.0946 .","journal-title":"Eur J Dermatol EJD."},{"issue":"6","key":"269_CR102","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1001\/archdermatol.2010.120","volume":"146","author":"M Diab","year":"2010","unstructured":"Diab M, Coloe JR, Magro C, Bechtel MA. Treatment of recalcitrant generalized morphea with infliximab. Arch Dermatol. 2010;146(6):601\u20134. doi: 10.1001\/archdermatol.2010.120 .","journal-title":"Arch Dermatol"},{"key":"269_CR103","doi-asserted-by":"publisher","first-page":"30","DOI":"10.2174\/18743129014090100030","volume":"9","author":"ID Ferguson","year":"2015","unstructured":"Ferguson ID, Weiser P, Torok KS. A case report of successful treatment of recalcitrant childhood localized scleroderma with infliximab and leflunomide. Open Rheumatol J. 2015;9:30\u20135. doi: 10.2174\/18743129014090100030 .","journal-title":"Open Rheumatol J"},{"issue":"1","key":"269_CR104","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.jaad.2008.03.009","volume":"59","author":"A Peroni","year":"2008","unstructured":"Peroni A, Zini A, Braga V, Colato C, Adami S, Girolomoni G. Drug-induced morphea: report of a case induced by balicatib and review of the literature. J Am Acad Dermatol. 2008;59(1):125\u20139. doi: 10.1016\/j.jaad.2008.03.009 .","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"269_CR105","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/00000372-199610000-00004","volume":"18","author":"SR Granter","year":"1996","unstructured":"Granter SR, Barnhill RL, Duray PH. Borrelial fasciitis: diffuse fasciitis and peripheral eosinophilia associated with Borrelia infection. Am J Dermatopathol. 1996;18(5):465\u201373.","journal-title":"Am J Dermatopathol"},{"issue":"6","key":"269_CR106","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/s10067-009-1122-2","volume":"28","author":"NS Sherber","year":"2009","unstructured":"Sherber NS, Wigley FM, Paget SA. Diffuse fasciitis with eosinophilia developing after local irradiation for breast cancer. Clin Rheumatol. 2009;28(6):729\u201332. doi: 10.1007\/s10067-009-1122-2 .","journal-title":"Clin Rheumatol"},{"issue":"3","key":"269_CR107","first-page":"114","volume":"8","author":"JR Mallepalli","year":"2008","unstructured":"Mallepalli JR, Quinet RJ, Sus R. Eosinophilic fasciitis induced by fire ant bites. Ochsner J. 2008;8(3):114\u20138.","journal-title":"Ochsner J."},{"issue":"11","key":"269_CR108","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1002\/art.38098","volume":"65","author":"F Hoogen van den","year":"2013","unstructured":"van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, et al. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League against Rheumatism collaborative initiative. Arthritis Rheum. 2013;65(11):2737\u201347. doi: 10.1002\/art.38098 .","journal-title":"Arthritis Rheum"},{"issue":"5","key":"269_CR109","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1111\/j.1525-1470.2010.01258.x","volume":"27","author":"M Beltramelli","year":"2010","unstructured":"Beltramelli M, Vercellesi P, Frasin A, Gelmetti C, Corona F. Localized severe scleroderma: a retrospective study of 26 pediatric patients. Pediatr Dermatol. 2010;27(5):476\u201380. doi: 10.1111\/j.1525-1470.2010.01258.x .","journal-title":"Pediatr Dermatol"},{"issue":"2","key":"269_CR110","doi-asserted-by":"publisher","first-page":"65","DOI":"10.5114\/pdia.2014.40978","volume":"31","author":"A Lis-Swiety","year":"2014","unstructured":"Lis-Swiety A, Brzezinska-Wcislo L, Arasiewicz H, Bergler-Czop B. Antiphospholipid antibodies in localized scleroderma: the potential role of screening tests for the detection of antiphospholipid syndrome. Postepy dermatol Alergol. 2014;31(2):65\u201370. doi: 10.5114\/pdia.2014.40978 .","journal-title":"Postepy dermatol Alergol."},{"issue":"8","key":"269_CR111","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1136\/ard.62.8.771","volume":"62","author":"S Sato","year":"2003","unstructured":"Sato S, Fujimoto M, Hasegawa M, Takehara K. Antiphospholipid antibody in localised scleroderma. Ann Rheum Dis. 2003;62(8):771\u20134.","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"269_CR112","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s004030100254","volume":"293","author":"K Yamane","year":"2001","unstructured":"Yamane K, Ihn H, Kubo M, Kuwana M, Asano Y, Yazawa N, et al. Anti-U1RNP antibodies in patients with localized scieroderma. Arch Dermatol Res. 2001;293(9):455\u20139.","journal-title":"Arch Dermatol Res"},{"issue":"12","key":"269_CR113","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1136\/ard.60.12.1157","volume":"60","author":"K Yimane","year":"2001","unstructured":"Yimane K, Ihn H, Kubo M, Asano Y, Yazawa N, Tamaki K. Anti-U3 snRNP antibodies in localised scleroderma. Ann Rheum Dis. 2001;60(12):1157\u20138.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"269_CR114","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jdermsci.2008.04.013","volume":"52","author":"S Tomimura","year":"2008","unstructured":"Tomimura S, Ogawa F, Iwata Y, Komura K, Hara T, Muroi E, et al. Autoantibodies against matrix metalloproteinase-1 in patients with localized scleroderma. J Dermatol Sci. 2008;52(1):47\u201354. doi: 10.1016\/j.jdermsci.2008.04.013 .","journal-title":"J Dermatol Sci"},{"issue":"9","key":"269_CR115","doi-asserted-by":"publisher","first-page":"2926","DOI":"10.1002\/art.21250","volume":"52","author":"RA Sinico","year":"2005","unstructured":"Sinico RA, Di Toma L, Maggiore U, Bottero P, Radice A, Tosoni C, et al. Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg\u2013Strauss syndrome. Arthritis Rheum. 2005;52(9):2926\u201335. doi: 10.1002\/art.21250 .","journal-title":"Arthritis Rheum"},{"key":"269_CR116","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.13790","author":"A Lis-Swiety","year":"2016","unstructured":"Lis-Swiety A, Janicka I, Skrzypek-Salamon A, Brzezinska-Wcislo L. A systematic review of tools for determining activity of localized scleroderma in paediatric and adult patients. J Eur Acad Dermatol Venereol JEADV. 2016;. doi: 10.1111\/jdv.13790 .","journal-title":"J Eur Acad Dermatol Venereol JEADV."},{"issue":"12","key":"269_CR117","doi-asserted-by":"publisher","first-page":"2819","DOI":"10.3899\/jrheum.081284","volume":"36","author":"T Arkachaisri","year":"2009","unstructured":"Arkachaisri T, Vilaiyuk S, Li S, O\u2019Neil KM, Pope E, Higgins GC, et al. The localized scleroderma skin severity index and physician global assessment of disease activity: a work in progress toward development of localized scleroderma outcome measures. J Rheumatol. 2009;36(12):2819\u201329. doi: 10.3899\/jrheum.081284 .","journal-title":"J Rheumatol"},{"key":"269_CR118","doi-asserted-by":"publisher","unstructured":"Arkachaisri T, Vilaiyuk S, Torok KS, Medsger Jr TA. Development and initial validation of the localized scleroderma skin damage index and physician global assessment of disease damage: a proof-of-concept study. Rheumatology (Oxford, England) 2010;49(2):373\u201381. doi: 10.1093\/rheumatology\/kep361 .","DOI":"10.1093\/rheumatology\/kep361"},{"issue":"4","key":"269_CR119","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1111\/j.1365-2133.2005.06776.x","volume":"153","author":"M Dytoc","year":"2005","unstructured":"Dytoc M, Ting PT, Man J, Sawyer D, Fiorillo L. First case series on the use of imiquimod for morphoea. Br J Dermatol. 2005;153(4):815\u201320. doi: 10.1111\/j.1365-2133.2005.06776.x .","journal-title":"Br J Dermatol."},{"issue":"2","key":"269_CR120","doi-asserted-by":"publisher","first-page":"132","DOI":"10.2310\/7750.2014.14072","volume":"19","author":"M Dytoc","year":"2015","unstructured":"Dytoc M, Wat H, Cheung-Lee M, Sawyer D, Ackerman T, Fiorillo L. Evaluation of the efficacy and safety of topical imiquimod 5% for plaque-type morphea: a multicenter, prospective, vehicle-controlled trial. J Cutan Med Surg. 2015;19(2):132\u20139. doi: 10.2310\/7750.2014.14072 .","journal-title":"J Cutan Med Surg."},{"key":"269_CR121","doi-asserted-by":"crossref","unstructured":"de Rie MA, Enomoto DN, de Vries HJ, Bos JD. Evaluation of medium-dose UVA1 phototherapy in localized scleroderma with the Cutometer and fast Fourier transform method. Dermatology (Basel, Switzerland) 2003;207(3):298\u2013301.","DOI":"10.1159\/000073093"},{"issue":"2","key":"269_CR122","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1111\/j.1365-2133.2009.09438.x","volume":"162","author":"C Andres","year":"2010","unstructured":"Andres C, Kollmar A, Mempel M, Hein R, Ring J, Eberlein B. Successful ultraviolet al phototherapy in the treatment of localized scleroderma: a retrospective and prospective study. Br J Dermatol. 2010;162(2):445\u20137. doi: 10.1111\/j.1365-2133.2009.09438.x .","journal-title":"Br J Dermatol."},{"issue":"5","key":"269_CR123","doi-asserted-by":"publisher","first-page":"869","DOI":"10.3109\/14397595.2013.844301","volume":"24","author":"F Porta","year":"2014","unstructured":"Porta F, Kaloudi O, Garzitto A, Prignano F, Nacci F, Falcini F, et al. High frequency ultrasound can detect improvement of lesions in juvenile localized scleroderma. Mod Rheumatol\/Jpn Rheum Assoc. 2014;24(5):869\u201373. doi: 10.3109\/14397595.2013.844301 .","journal-title":"Mod Rheumatol\/Jpn Rheum Assoc."},{"issue":"5 Pt 1","key":"269_CR124","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S0190-9622(97)70121-X","volume":"37","author":"MM Seyger","year":"1997","unstructured":"Seyger MM, van den Hoogen FH, de Boo T, de Jong EM. Reliability of two methods to assess morphea: skin scoring and the use of a durometer. J Am Acad Dermatol. 1997;37(5 Pt 1):793\u20136.","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"269_CR125","doi-asserted-by":"crossref","first-page":"444","DOI":"10.2340\/0001555574444446","volume":"74","author":"H Zachariae","year":"1994","unstructured":"Zachariae H, Bjerring P, Halkier-Sorensen L, Heickendorff L, Sondergaard K. Skin scoring in systemic sclerosis: a modification\u2013relations to subtypes and the aminoterminal propeptide of type III procollagen (PIIINP). Acta Dermato Venereol. 1994;74(6):444\u20136.","journal-title":"Acta Dermato Venereol."},{"key":"269_CR126","doi-asserted-by":"publisher","unstructured":"Zulian F, Meneghesso D, Grisan E, Vittadello F, Belloni Fortina A, Pigozzi B, et al. A new computerized method for the assessment of skin lesions in localized scleroderma. Rheumatology (Oxford, England) 2007;46(5):856\u201360. doi: 10.1093\/rheumatology\/kel446 .","DOI":"10.1093\/rheumatology\/kel446"},{"issue":"5","key":"269_CR127","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1002\/acr.20407","volume":"63","author":"SC Li","year":"2011","unstructured":"Li SC, Liebling MS, Haines KA, Weiss JE, Prann A. Initial evaluation of an ultrasound measure for assessing the activity of skin lesions in juvenile localized scleroderma. Arthritis Care Res. 2011;63(5):735\u201342. doi: 10.1002\/acr.20407 .","journal-title":"Arthritis Care Res"},{"issue":"1","key":"269_CR128","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1111\/bjd.14103","volume":"174","author":"S Poff","year":"2016","unstructured":"Poff S, Li SC, Kelsey CE, Foeldvari I, Torok KS. Durometry as an outcome measure in juvenile localized scleroderma. Br J Dermatol. 2016;174(1):228\u201330. doi: 10.1111\/bjd.14103 .","journal-title":"Br J Dermatol."},{"issue":"8","key":"269_CR129","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1007\/s00296-011-1993-9","volume":"32","author":"KW Moon","year":"2012","unstructured":"Moon KW, Song R, Kim JH, Lee EY, Lee EB, Song YW. The correlation between durometer score and modified Rodnan skin score in systemic sclerosis. Rheumatol Int. 2012;32(8):2465\u201370. doi: 10.1007\/s00296-011-1993-9 .","journal-title":"Rheumatol Int"},{"issue":"1","key":"269_CR130","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0190-9622(93)70150-R","volume":"29","author":"V Falanga","year":"1993","unstructured":"Falanga V, Bucalo B. Use of a durometer to assess skin hardness. J Am Acad Dermatol. 1993;29(1):47\u201351.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"269_CR131","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1148\/radiol.11102136","volume":"260","author":"S Schanz","year":"2011","unstructured":"Schanz S, Fierlbeck G, Ulmer A, Schmalzing M, Kummerle-Deschner J, Claussen CD, et al. Localized scleroderma: MR findings and clinical features. Radiology. 2011;260(3):817\u201324. doi: 10.1148\/radiol.11102136 .","journal-title":"Radiology"},{"issue":"4","key":"269_CR132","doi-asserted-by":"publisher","first-page":"392","DOI":"10.3881\/j.issn.1000-503X.2015.04.004","volume":"37","author":"FD Wang","year":"2015","unstructured":"Wang FD, Wang HW, Wu ZH, Hou B, Jiang B, Zhang Y, et al. Localized scleroderma of lower extremities: clinical and magnetic resonance imaging features. Zhongguo Yi Xue Ke Xue Yuan Xue Bao Acta Acad Med Sin. 2015;37(4):392\u20137. doi: 10.3881\/j.issn.1000-503X.2015.04.004 .","journal-title":"Zhongguo Yi Xue Ke Xue Yuan Xue Bao Acta Acad Med Sin"},{"issue":"4","key":"269_CR133","doi-asserted-by":"publisher","first-page":"W376","DOI":"10.2214\/ajr.12.9335","volume":"200","author":"S Schanz","year":"2013","unstructured":"Schanz S, Henes J, Ulmer A, Kotter I, Fierlbeck G, Claussen CD, et al. Response evaluation of musculoskeletal involvement in patients with deep morphea treated with methotrexate and prednisolone: a combined MRI and clinical approach. AJR Am J Roentgenol. 2013;200(4):W376\u201382. doi: 10.2214\/ajr.12.9335 .","journal-title":"AJR Am J Roentgenol"},{"key":"269_CR134","doi-asserted-by":"publisher","unstructured":"Saad Magalhaes C, de Albuquerque Pedrosa Fernandes T, Dias Fernandes T, de Lima Resende LA. A cross-sectional electromyography assessment in linear scleroderma patients. Pediatr Rheumatol Online J. 2014;12:27. doi: 10.1186\/1546-0096-12-27 .","DOI":"10.1186\/1546-0096-12-27"},{"issue":"4","key":"269_CR135","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1097\/CND.0b013e318175c495","volume":"9","author":"NC Voermans","year":"2008","unstructured":"Voermans NC, Pillen S, de Jong EM, Creemers MC, Lammens M, van Alfen N. Morphea profunda presenting as a neuromuscular mimic. J Clin Neuromuscul Dis. 2008;9(4):407\u201314. doi: 10.1097\/CND.0b013e318175c495 .","journal-title":"J Clin Neuromuscul Dis."},{"issue":"3","key":"269_CR136","doi-asserted-by":"publisher","first-page":"975","DOI":"10.2214\/ajr.184.3.01840975","volume":"184","author":"SJ Moulton","year":"2005","unstructured":"Moulton SJ, Kransdorf MJ, Ginsburg WW, Abril A, Persellin S. Eosinophilic fasciitis: spectrum of MRI findings. AJR Am J Roentgenol. 2005;184(3):975\u20138. doi: 10.2214\/ajr.184.3.01840975 .","journal-title":"AJR Am J Roentgenol"},{"issue":"10","key":"269_CR137","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1136\/ard.2008.103903","volume":"68","author":"M Ronneberger","year":"2009","unstructured":"Ronneberger M, Janka R, Schett G, Manger B. Can MRI substitute for biopsy in eosinophilic fasciitis? Ann Rheum Dis. 2009;68(10):1651\u20132. doi: 10.1136\/ard.2008.103903 .","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"269_CR138","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1007\/s10067-010-1508-1","volume":"29","author":"A Desvignes-Engelbert","year":"2010","unstructured":"Desvignes-Engelbert A, Sauliere N, Loeuille D, Blum A, Chary-Valckenaere I. From diagnosis to remission: place of MRI in eosinophilic fasciitis. Clin Rheumatol. 2010;29(12):1461\u20134. doi: 10.1007\/s10067-010-1508-1 .","journal-title":"Clin Rheumatol"},{"issue":"2","key":"269_CR139","doi-asserted-by":"publisher","first-page":"e191","DOI":"10.1111\/j.1468-3083.2012.04581.x","volume":"27","author":"F Succaria","year":"2013","unstructured":"Succaria F, Kurban M, Kibbi AG, Abbas O. Clinicopathological study of 81 cases of localized and systemic scleroderma. J Eur Acad Dermatol Venereol JEADV. 2013;27(2):e191\u20136. doi: 10.1111\/j.1468-3083.2012.04581.x .","journal-title":"J Eur Acad Dermatol Venereol JEADV."},{"issue":"3","key":"269_CR140","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/00000372-199806000-00003","volume":"20","author":"JE Torres","year":"1998","unstructured":"Torres JE, Sanchez JL. Histopathologic differentiation between localized and systemic scleroderma. Am J Dermatopathol. 1998;20(3):242\u20135.","journal-title":"Am J Dermatopathol."},{"issue":"11","key":"269_CR141","doi-asserted-by":"publisher","first-page":"3633","DOI":"10.1002\/art.30514","volume":"63","author":"JA Allen","year":"2011","unstructured":"Allen JA, Peterson A, Sufit R, Hinchcliff ME, Mahoney JM, Wood TA, et al. Post-epidemic eosinophilia-myalgia syndrome associated with l-tryptophan. Arthritis Rheum. 2011;63(11):3633\u20139. doi: 10.1002\/art.30514 .","journal-title":"Arthritis Rheum"},{"issue":"6","key":"269_CR142","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1097\/00002281-199511000-00016","volume":"7","author":"LD Kaufman","year":"1995","unstructured":"Kaufman LD, Krupp LB. Eosinophilia-myalgia syndrome, toxic-oil syndrome, and diffuse fasciitis with eosinophilia. Curr Opin Rheumatol. 1995;7(6):560\u20137.","journal-title":"Curr Opin Rheumatol"},{"issue":"9","key":"269_CR143","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.3324\/haematol.2009.010421","volume":"94","author":"F Roufosse","year":"2009","unstructured":"Roufosse F. Hypereosinophilic syndrome variants: diagnostic and therapeutic considerations. Haematologica. 2009;94(9):1188\u201393. doi: 10.3324\/haematol.2009.010421 .","journal-title":"Haematologica"},{"key":"269_CR144","doi-asserted-by":"publisher","unstructured":"Noth I, Strek ME, Leff AR. Churg\u2013Strauss syndrome. Lancet (London, England) 2003;361(9357):587\u201394. doi: 10.1016\/S0140-6736(03)12518-4 .","DOI":"10.1016\/S0140-6736(03)12518-4"},{"issue":"6","key":"269_CR145","doi-asserted-by":"publisher","first-page":"e1715","DOI":"10.1542\/peds.2014-0019","volume":"134","author":"I Polcari","year":"2014","unstructured":"Polcari I, Moon A, Mathes EF, Gilmore ES, Paller AS. Headaches as a presenting symptom of linear morphea en coup de sabre. Pediatrics. 2014;134(6):e1715\u20139. doi: 10.1542\/peds.2014-0019 .","journal-title":"Pediatrics"},{"issue":"6","key":"269_CR146","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1111\/pde.12001","volume":"29","author":"YE Chiu","year":"2012","unstructured":"Chiu YE, Vora S, Kwon EK, Maheshwari M. A significant proportion of children with morphea en coup de sabre and Parry\u2013Romberg syndrome have neuroimaging findings. Pediatr Dermatol. 2012;29(6):738\u201348. doi: 10.1111\/pde.12001 .","journal-title":"Pediatr Dermatol"},{"issue":"9","key":"269_CR147","first-page":"1997","volume":"30","author":"M Blaszczyk","year":"2003","unstructured":"Blaszczyk M, Krolicki L, Krasu M, Glinska O, Jablonska S. Progressive facial hemiatrophy: central nervous system involvement and relationship with scleroderma en coup de sabre. J Rheumatol. 2003;30(9):1997\u20132004.","journal-title":"J Rheumatol"},{"issue":"9","key":"269_CR148","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1212\/01.WNL.0000124518.25087.18","volume":"62","author":"S Appenzeller","year":"2004","unstructured":"Appenzeller S, Montenegro MA, Dertkigil SS, Sampaio-Barros PD, Marques-Neto JF, Samara AM, et al. Neuroimaging findings in scleroderma en coup de sabre. Neurology. 2004;62(9):1585\u20139.","journal-title":"Neurology."},{"key":"269_CR149","doi-asserted-by":"publisher","first-page":"719685","DOI":"10.1155\/2012\/719685","volume":"2012","author":"TN Amaral","year":"2012","unstructured":"Amaral TN, Marques Neto JF, Lapa AT, Peres FA, Guirau CR, Appenzeller S. Neurologic involvement in scleroderma en coup de sabre. Autoimmune Dis. 2012;2012:719685. doi: 10.1155\/2012\/719685 .","journal-title":"Autoimmune Dis"},{"issue":"1","key":"269_CR150","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s00234-014-1448-6","volume":"57","author":"DA Doolittle","year":"2015","unstructured":"Doolittle DA, Lehman VT, Schwartz KM, Wong-Kisiel LC, Lehman JS, Tollefson MM. CNS imaging findings associated with Parry\u2013Romberg syndrome and en coup de sabre: correlation to dermatologic and neurologic abnormalities. Neuroradiology. 2015;57(1):21\u201334. doi: 10.1007\/s00234-014-1448-6 .","journal-title":"Neuroradiology"},{"issue":"1","key":"269_CR151","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/j.1365-4632.2007.03544.x","volume":"47","author":"L Bischoff","year":"2008","unstructured":"Bischoff L, Derk CT. Eosinophilic fasciitis: demographics, disease pattern and response to treatment: report of 12 cases and review of the literature. Int J Dermatol. 2008;47(1):29\u201335. doi: 10.1111\/j.1365-4632.2007.03544.x .","journal-title":"Int J Dermatol"},{"issue":"3","key":"269_CR152","doi-asserted-by":"publisher","first-page":"181","DOI":"10.2165\/00128071-200910030-00004","volume":"10","author":"EB Kroft","year":"2009","unstructured":"Kroft EB, Groeneveld TJ, Seyger MM, de Jong EM. Efficacy of topical tacrolimus 0.1% in active plaque morphea: randomized, double-blind, emollient-controlled pilot study. Am J Clin Dermatol. 2009;10(3):181\u20137. doi: 10.2165\/00128071-200910030-00004 .","journal-title":"Am J Clin Dermatol"},{"issue":"1","key":"269_CR153","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1111\/j.1365-2133.2004.06318.x","volume":"152","author":"G Mancuso","year":"2005","unstructured":"Mancuso G, Berdondini RM. Localized scleroderma: response to occlusive treatment with tacrolimus ointment. Br J Dermatol. 2005;152(1):180\u20132. doi: 10.1111\/j.1365-2133.2004.06318.x .","journal-title":"Br J Dermatol"},{"issue":"11","key":"269_CR154","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1111\/j.1346-8138.2008.00552.x","volume":"35","author":"C Stefanaki","year":"2008","unstructured":"Stefanaki C, Stefanaki K, Kontochristopoulos G, Antoniou C, Stratigos A, Nicolaidou E, et al. Topical tacrolimus 0.1% ointment in the treatment of localized scleroderma. An open label clinical and histological study. J Dermatol. 2008;35(11):712\u20138. doi: 10.1111\/j.1346-8138.2008.00552.x .","journal-title":"J Dermatol"},{"key":"269_CR155","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.13739","author":"CH Chu","year":"2016","unstructured":"Chu CH, Cheng YP, Liang CW, Chiu HC, Jee SH, Lisa Chan JY, et al. Radiation recall dermatitis induced by topical tacrolimus for post-irradiation morphea. J Eur Acad Dermatol Venereol JEADV. 2016;. doi: 10.1111\/jdv.13739 .","journal-title":"J Eur Acad Dermatol Venereol JEADV."},{"issue":"2 Pt 1","key":"269_CR156","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0190-9622(98)70077-5","volume":"39","author":"BB Cunningham","year":"1998","unstructured":"Cunningham BB, Landells ID, Langman C, Sailer DE, Paller AS. Topical calcipotriene for morphea\/linear scleroderma. J Am Acad Dermatol. 1998;39(2 Pt 1):211\u20135.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"269_CR157","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1046\/j.1525-1470.2001.018003241.x","volume":"18","author":"A Kreuter","year":"2001","unstructured":"Kreuter A, Gambichler T, Avermaete A, Jansen T, Hoffmann M, Hoffmann K, et al. Combined treatment with calcipotriol ointment and low-dose ultraviolet al phototherapy in childhood morphea. Pediatr Dermatol. 2001;18(3):241\u20135.","journal-title":"Pediatr Dermatol"},{"issue":"3","key":"269_CR158","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1111\/j.1365-2133.2007.07971.x","volume":"157","author":"MT Dytoc","year":"2007","unstructured":"Dytoc MT, Kossintseva I, Ting PT. First case series on the use of calcipotriol-betamethasone dipropionate for morphoea. Br J Dermatol. 2007;157(3):615\u20138. doi: 10.1111\/j.1365-2133.2007.07971.x .","journal-title":"Br J Dermatol."},{"key":"269_CR159","doi-asserted-by":"publisher","unstructured":"Pope E, Doria AS, Theriault M, Mohanta A, Laxer RM. Topical imiquimod 5% cream for pediatric plaque morphea: a prospective, multiple-baseline, open-label pilot study. Dermatology (Basel, Switzerland) 2011;223(4):363\u20139. doi: 10.1159\/000335560 .","DOI":"10.1159\/000335560"},{"issue":"3","key":"269_CR160","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1007\/s10227-003-0112-2","volume":"8","author":"J Man","year":"2004","unstructured":"Man J, Dytoc MT. Use of imiquimod cream 5% in the treatment of localized morphea. J Cutan Med Surg. 2004;8(3):166\u20139. doi: 10.1007\/s10227-003-0112-2 .","journal-title":"J Cutan Med Surg."},{"issue":"1","key":"269_CR161","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1080\/09546630802132668","volume":"20","author":"E Campione","year":"2009","unstructured":"Campione E, Paterno EJ, Diluvio L, Orlandi A, Bianchi L, Chimenti S. Localized morphea treated with imiquimod 5% and dermoscopic assessment of effectiveness. J Dermatol Treat. 2009;20(1):10\u20133. doi: 10.1080\/09546630802132668 .","journal-title":"J Dermatol Treat."},{"issue":"6","key":"269_CR162","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1186\/s13075-014-0510-4","volume":"16","author":"M Rodriguez-Castellanos","year":"2014","unstructured":"Rodriguez-Castellanos M, Tlacuilo-Parra A, Sanchez-Enriquez S, Velez-Gomez E, Guevara-Gutierrez E. Pirfenidone gel in patients with localized scleroderma: a phase II study. Arthritis Res Ther. 2014;16(6):510. doi: 10.1186\/s13075-014-0510-4 .","journal-title":"Arthritis Res Ther."},{"issue":"2","key":"269_CR163","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1067\/mjd.2002.118552","volume":"46","author":"A Kreuter","year":"2002","unstructured":"Kreuter A, Gambichler T, Avermaete A, Happe M, Bacharach-Buhles M, Hoffmann K, et al. Low-dose ultraviolet al phototherapy for extragenital lichen sclerosus: results of a preliminary study. J Am Acad Dermatol. 2002;46(2):251\u20135.","journal-title":"J Am Acad Dermatol"},{"issue":"6 Pt 1","key":"269_CR164","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/S0190-9622(97)80277-0","volume":"36","author":"H Stege","year":"1997","unstructured":"Stege H, Berneburg M, Humke S, Klammer M, Grewe M, Grether-Beck S, et al. High-dose UVA1 radiation therapy for localized scleroderma. J Am Acad Dermatol. 1997;36(6 Pt 1):938\u201344.","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"269_CR165","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1034\/j.1600-0781.2001.170401.x","volume":"17","author":"CJ Gruss","year":"2001","unstructured":"Gruss CJ, Von Kobyletzki G, Behrens-Williams SC, Lininger J, Reuther T, Kerscher M, et al. Effects of low dose ultraviolet A-1 phototherapy on morphea. Photodermatol Photoimmunol Photomed. 2001;17(4):149\u201355.","journal-title":"Photodermatol Photoimmunol Photomed"},{"issue":"1","key":"269_CR166","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0190-9622(98)70533-X","volume":"38","author":"M Kerscher","year":"1998","unstructured":"Kerscher M, Volkenandt M, Gruss C, Reuther T, von Kobyletzki G, Freitag M, et al. Low-dose UVA phototherapy for treatment of localized scleroderma. J Am Acad Dermatol. 1998;38(1):21\u20136.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"269_CR167","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.jaad.2005.11.1063","volume":"54","author":"A Kreuter","year":"2006","unstructured":"Kreuter A, Hyun J, Stucker M, Sommer A, Altmeyer P, Gambichler T. A randomized controlled study of low-dose UVA1, medium-dose UVA1, and narrowband UVB phototherapy in the treatment of localized scleroderma. J Am Acad Dermatol. 2006;54(3):440\u20137. doi: 10.1016\/j.jaad.2005.11.1063 .","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"269_CR168","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.jaad.2008.12.013","volume":"60","author":"PG Sator","year":"2009","unstructured":"Sator PG, Radakovic S, Schulmeister K, Honigsmann H, Tanew A. Medium-dose is more effective than low-dose ultraviolet al phototherapy for localized scleroderma as shown by 20-MHz ultrasound assessment. J Am Acad Dermatol. 2009;60(5):786\u201391. doi: 10.1016\/j.jaad.2008.12.013 .","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"269_CR169","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1067\/mjd.2001.117735","volume":"45","author":"NR Camacho","year":"2001","unstructured":"Camacho NR, Sanchez JE, Martin RF, Gonzalez JR, Sanchez JL. Medium-dose UVA1 phototherapy in localized scleroderma and its effect in CD34-positive dendritic cells. J Am Acad Dermatol. 2001;45(5):697\u20139. doi: 10.1067\/mjd.2001.117735 .","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"269_CR170","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1111\/j.1365-4632.2010.04843.x","volume":"50","author":"O Su","year":"2011","unstructured":"Su O, Onsun N, Onay HK, Erdemoglu Y, Ozkaya DB, Cebeci F, et al. Effectiveness of medium-dose ultraviolet al phototherapy in localized scleroderma. Int J Dermatol. 2011;50(8):1006\u201313. doi: 10.1111\/j.1365-4632.2010.04843.x .","journal-title":"Int J Dermatol"},{"issue":"3","key":"269_CR171","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1111\/j.1600-0781.2004.00081.x","volume":"20","author":"M El-Mofty","year":"2004","unstructured":"El-Mofty M, Mostafa W, El-Darouty M, Bosseila M, Nada H, Yousef R, et al. Different low doses of broad-band UVA in the treatment of morphea and systemic sclerosis. Photodermatol Photoimmunol Photomed. 2004;20(3):148\u201356. doi: 10.1111\/j.1600-0781.2004.00081.x .","journal-title":"Photodermatol Photoimmunol Photomed"},{"issue":"11","key":"269_CR172","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1001\/archderm.1996.03890350014001","volume":"132","author":"M Kerscher","year":"1996","unstructured":"Kerscher M, Meurer M, Sander C, Volkenandt M, Lehmann P, Plewig G, et al. PUVA bath photochemotherapy for localized scleroderma. Evaluation of 17 consecutive patients. Arch Dermatol. 1996;132(11):1280\u20132.","journal-title":"Arch Dermatol"},{"issue":"6","key":"269_CR173","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1111\/j.1365-2230.2008.02890.x","volume":"33","author":"N Usmani","year":"2008","unstructured":"Usmani N, Murphy A, Veale D, Goulden V, Goodfield M. Photochemotherapy for localized morphoea: effect on clinical and molecular markers. Clin Exp Dermatol. 2008;33(6):698\u2013704. doi: 10.1111\/j.1365-2230.2008.02890.x .","journal-title":"Clin Exp Dermatol"},{"issue":"5","key":"269_CR174","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/phpp.12063","volume":"29","author":"F Pavlotsky","year":"2013","unstructured":"Pavlotsky F, Sakka N, Lozinski A, Barzilai A. Bath psoralen-UVA photochemotherapy for localized scleroderma: experience from a single institute. Photodermatol Photoimmunol Photomed. 2013;29(5):247\u201352. doi: 10.1111\/phpp.12063 .","journal-title":"Photodermatol Photoimmunol Photomed"},{"issue":"5","key":"269_CR175","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1001\/archderm.1994.01690050133027","volume":"130","author":"P Joly","year":"1994","unstructured":"Joly P, Bamberger N, Crickx B, Belaich S. Treatment of severe forms of localized scleroderma with oral corticosteroids: follow-up study on 17 patients. Arch Dermatol. 1994;130(5):663\u20134.","journal-title":"Arch Dermatol"},{"issue":"9","key":"269_CR176","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1111\/jdv.12039","volume":"27","author":"M Amy de la Breteque","year":"2013","unstructured":"Amy de la Breteque M, Rybojad M, Cordoliani F, Petit A, Juillard C, Flageul B, et al. Relapse of severe forms of adult morphea after oral corticosteroid treatment. J Eur Acad Dermatol Venereol JEADV. 2013;27(9):1190\u20131. doi: 10.1111\/jdv.12039 .","journal-title":"J Eur Acad Dermatol Venereol JEADV."},{"issue":"1","key":"269_CR177","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0022-3476(00)90056-8","volume":"136","author":"Y Uziel","year":"2000","unstructured":"Uziel Y, Feldman BM, Krafchik BR, Yeung RS, Laxer RM. Methotrexate and corticosteroid therapy for pediatric localized scleroderma. J Pediatr. 2000;136(1):91\u20135.","journal-title":"J Pediatr."},{"issue":"2","key":"269_CR178","doi-asserted-by":"publisher","first-page":"286","DOI":"10.3899\/jrheum.110210","volume":"39","author":"KS Torok","year":"2012","unstructured":"Torok KS, Arkachaisri T. Methotrexate and corticosteroids in the treatment of localized scleroderma: a standardized prospective longitudinal single-center study. J Rheumatol. 2012;39(2):286\u201394. doi: 10.3899\/jrheum.110210 .","journal-title":"J Rheumatol."},{"issue":"7","key":"269_CR179","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1001\/archderm.141.7.847","volume":"141","author":"A Kreuter","year":"2005","unstructured":"Kreuter A, Gambichler T, Breuckmann F, Rotterdam S, Freitag M, Stuecker M, et al. Pulsed high-dose corticosteroids combined with low-dose methotrexate in severe localized scleroderma. Arch Dermatol. 2005;141(7):847\u201352. doi: 10.1001\/archderm.141.7.847 .","journal-title":"Arch Dermatol"},{"issue":"2 Pt 1","key":"269_CR180","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S0190-9622(98)70079-9","volume":"39","author":"MM Seyger","year":"1998","unstructured":"Seyger MM, van den Hoogen FH, de Boo T, de Jong EM. Low-dose methotrexate in the treatment of widespread morphea. J Am Acad Dermatol. 1998;39(2 Pt 1):220\u20135.","journal-title":"J Am Acad Dermatol"},{"key":"269_CR181","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-2411","author":"JS Mertens","year":"2016","unstructured":"Mertens JS, van den Reek JM, Kievit W, van de Kerkhof PC, Thurlings RM, Radstake TR, et al. Drug survival and predictors of drug survival for methotrexate treatment in a retrospective cohort of adult patients with localized scleroderma. Acta Dermato Venereol. 2016;. doi: 10.2340\/00015555-2411 .","journal-title":"Acta Dermato Venereol."},{"issue":"5","key":"269_CR182","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1111\/j.1365-2133.2006.07497.x","volume":"155","author":"L Weibel","year":"2006","unstructured":"Weibel L, Sampaio MC, Visentin MT, Howell KJ, Woo P, Harper JI. Evaluation of methotrexate and corticosteroids for the treatment of localized scleroderma (morphoea) in children. Br J Dermatol. 2006;155(5):1013\u201320. doi: 10.1111\/j.1365-2133.2006.07497.x .","journal-title":"Br J Dermatol."},{"issue":"3","key":"269_CR183","first-page":"609","volume":"33","author":"PG Fitch","year":"2006","unstructured":"Fitch PG, Rettig P, Burnham JM, Finkel TH, Yan AC, Akin E, et al. Treatment of pediatric localized scleroderma with methotrexate. J Rheumatol. 2006;33(3):609\u201314.","journal-title":"J Rheumatol."},{"issue":"4","key":"269_CR184","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s11845-008-0217-0","volume":"177","author":"D Cox","year":"2008","unstructured":"Cox D, Or G, Collins S, Byrne A, Irvine A, Watson R. Juvenile localised scleroderma: a retrospective review of response to systemic treatment. Ir J Med Sci. 2008;177(4):343\u20136. doi: 10.1007\/s11845-008-0217-0 .","journal-title":"Ir J Med Sci"},{"issue":"5","key":"269_CR185","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1111\/j.1365-2133.2008.09017.x","volume":"160","author":"EB Kroft","year":"2009","unstructured":"Kroft EB, Creemers MC, van den Hoogen FH, Boezeman JB, de Jong EM. Effectiveness, side-effects and period of remission after treatment with methotrexate in localized scleroderma and related sclerotic skin diseases: an inception cohort study. Br J Dermatol. 2009;160(5):1075\u201382. doi: 10.1111\/j.1365-2133.2008.09017.x .","journal-title":"Br J Dermatol."},{"issue":"6","key":"269_CR186","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/j.jaad.2012.03.036","volume":"67","author":"F Zulian","year":"2012","unstructured":"Zulian F, Vallongo C, Patrizi A, Belloni-Fortina A, Cutrone M, Alessio M, et al. A long-term follow-up study of methotrexate in juvenile localized scleroderma (morphea). J Am Acad Dermatol. 2012;67(6):1151\u20136. doi: 10.1016\/j.jaad.2012.03.036 .","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"269_CR187","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1002\/acr.21687","volume":"64","author":"SC Li","year":"2012","unstructured":"Li SC, Torok KS, Pope E, Dedeoglu F, Hong S, Jacobe HT, et al. Development of consensus treatment plans for juvenile localized scleroderma: a roadmap toward comparative effectiveness studies in juvenile localized scleroderma. Arthritis Care Res. 2012;64(8):1175\u201385. doi: 10.1002\/acr.21687 .","journal-title":"Arthritis Care Res"},{"key":"269_CR188","doi-asserted-by":"publisher","unstructured":"Martini G, Ramanan AV, Falcini F, Girschick H, Goldsmith DP, Zulian F. Successful treatment of severe or methotrexate-resistant juvenile localized scleroderma with mycophenolate mofetil. Rheumatology (Oxford, England) 2009;48(11):1410\u20133. doi: 10.1093\/rheumatology\/kep244 .","DOI":"10.1093\/rheumatology\/kep244"},{"issue":"4","key":"269_CR189","doi-asserted-by":"publisher","first-page":"510","DOI":"10.2340\/00015555-2297","volume":"96","author":"JS Mertens","year":"2016","unstructured":"Mertens JS, Marsman D, van de Kerkhof PC, Hoppenreijs EP, Knaapen HK, Radstake TR, et al. Use of mycophenolate mofetil in patients with severe localized scleroderma resistant or intolerant to methotrexate. Acta Dermato Venereol. 2016;96(4):510\u20133. doi: 10.2340\/00015555-2297 .","journal-title":"Acta Dermato Venereol."},{"key":"269_CR190","doi-asserted-by":"publisher","unstructured":"Hawley DP, Pain CE, Baildam EM, Murphy R, Taylor AE, Foster HE. United Kingdom survey of current management of juvenile localized scleroderma. Rheumatology (Oxford, England) 2014;53(10):1849\u201354. doi: 10.1093\/rheumatology\/keu212 .","DOI":"10.1093\/rheumatology\/keu212"},{"issue":"5","key":"269_CR191","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1111\/dth.12248","volume":"28","author":"CM Alcantara-Reifs","year":"2015","unstructured":"Alcantara-Reifs CM, Garnacho-Saucedo GM, Salido-Vallejo R, de la Corte-Sanchez S, Garcia-Nieto AV. Imatinib treatment of therapy resistant generalized deep morphea. Dermatol Ther. 2015;28(5):271\u20133. doi: 10.1111\/dth.12248 .","journal-title":"Dermatol Ther"},{"issue":"10","key":"269_CR192","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1111\/ijd.12387","volume":"53","author":"V Coelho-Macias","year":"2014","unstructured":"Coelho-Macias V, Mendes-Bastos P, Assis-Pacheco F, Cardoso J. Imatinib: a novel treatment approach for generalized morphea. Int J Dermatol. 2014;53(10):1299\u2013302. doi: 10.1111\/ijd.12387 .","journal-title":"Int J Dermatol"},{"issue":"6","key":"269_CR193","doi-asserted-by":"publisher","first-page":"e191","DOI":"10.1111\/j.1525-1470.2012.01882.x","volume":"30","author":"Y Inamo","year":"2013","unstructured":"Inamo Y, Ochiai T. Successful combination treatment of a patient with progressive juvenile localized scleroderma (morphea) using imatinib, corticosteroids, and methotrexate. Pediatr Dermatol. 2013;30(6):e191\u20133. doi: 10.1111\/j.1525-1470.2012.01882.x .","journal-title":"Pediatr Dermatol"},{"issue":"5","key":"269_CR194","doi-asserted-by":"publisher","first-page":"e102","DOI":"10.1016\/j.jaad.2010.02.030","volume":"63","author":"P Moinzadeh","year":"2010","unstructured":"Moinzadeh P, Krieg T, Hunzelmann N. Imatinib treatment of generalized localized scleroderma (morphea). J Am Acad Dermatol. 2010;63(5):e102\u20134. doi: 10.1016\/j.jaad.2010.02.030 .","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"269_CR195","doi-asserted-by":"publisher","first-page":"686","DOI":"10.2340\/00015555-1136","volume":"91","author":"B Stausbol-Gron","year":"2011","unstructured":"Stausbol-Gron B, Olesen AB, Deleuran B, Deleuran MS. Abatacept is a promising treatment for patients with disseminated morphea profunda: presentation of two cases. Acta Dermato Venereol. 2011;91(6):686\u20138. doi: 10.2340\/00015555-1136 .","journal-title":"Acta Dermato Venereol."},{"issue":"1","key":"269_CR196","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1684\/ejd.2015.2689","volume":"26","author":"A Hirohata","year":"2016","unstructured":"Hirohata A, Hanafusa T, Igawa K, Inoue-Nishimoto T, Mabuchi-Kiyohara E, Nishide M, et al. Oral tacrolimus for the treatment of generalized morphea. Eur J Dermatol EJD. 2016;26(1):112\u20133. doi: 10.1684\/ejd.2015.2689 .","journal-title":"Eur J Dermatol EJD."},{"key":"269_CR197","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2016.2338","author":"L Frumholtz","year":"2016","unstructured":"Frumholtz L, Roux J, Bagot M, Rybojad M, Bouaziz JD. Treatment of generalized deep morphea with everolimus. JAMA Dermatol. 2016;. doi: 10.1001\/jamadermatol.2016.2338 .","journal-title":"JAMA Dermatol."},{"issue":"5","key":"269_CR198","doi-asserted-by":"publisher","first-page":"779","DOI":"10.3727\/096368912X639017","volume":"22","author":"N Scuderi","year":"2013","unstructured":"Scuderi N, Ceccarelli S, Onesti MG, Fioramonti P, Guidi C, Romano F, et al. Human adipose-derived stromal cells for cell-based therapies in the treatment of systemic sclerosis. Cell Transplant. 2013;22(5):779\u201395. doi: 10.3727\/096368912X639017 .","journal-title":"Cell Transplant"},{"issue":"1","key":"269_CR199","first-page":"27","volume":"56","author":"CJ Michet Jr","year":"1981","unstructured":"Michet CJ Jr, Doyle JA, Ginsburg WW. Eosinophilic fasciitis: report of 15 cases. Mayo Clin Proc. 1981;56(1):27\u201334.","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"269_CR200","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/1756-185x.12499","volume":"18","author":"F Berianu","year":"2015","unstructured":"Berianu F, Cohen MD, Abril A, Ginsburg WW. Eosinophilic fasciitis: clinical characteristics and response to methotrexate. Int J Rheum Dis. 2015;18(1):91\u20138. doi: 10.1111\/1756-185x.12499 .","journal-title":"Int J Rheum Dis."},{"key":"269_CR201","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2016.2873","author":"JS Mertens","year":"2016","unstructured":"Mertens JS, Zweers MC, Kievit W, Knaapen HK, Gerritsen M, Radstake TR, et al. High-dose intravenous pulse methotrexate in patients with eosinophilic fasciitis. JAMA Dermatol. 2016;. doi: 10.1001\/jamadermatol.2016.2873 .","journal-title":"JAMA Dermatol."},{"issue":"2","key":"269_CR202","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3109\/03009742.2015.1067713","volume":"45","author":"FA Mendoza","year":"2016","unstructured":"Mendoza FA, Bai R, Kebede AG, Jimenez SA. Severe eosinophilic fasciitis: comparison of treatment with d-penicillamine plus corticosteroids vs. corticosteroids alone. Scand J Rheumatol. 2016;45(2):129\u201334. doi: 10.3109\/03009742.2015.1067713 .","journal-title":"Scand J Rheumatol"},{"key":"269_CR203","doi-asserted-by":"publisher","unstructured":"Khanna D, Agrawal H, Clements PJ. Infliximab may be effective in the treatment of steroid-resistant eosinophilic fasciitis: report of three cases. Rheumatology (Oxford, England) 2010;49(6):1184\u20138. doi: 10.1093\/rheumatology\/keq062 .","DOI":"10.1093\/rheumatology\/keq062"},{"issue":"4","key":"269_CR204","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3109\/03009747909114628","volume":"8","author":"VA Nassonova","year":"1979","unstructured":"Nassonova VA, Ivanova MM, Akhnazarova VD, Oskilko TG, Bjelle A, Hofer PA, et al. Eosinophilic fasciitis. Review and report of six cases. Scand J Rheumatol. 1979;8(4):225\u201333.","journal-title":"Scand J Rheumatol"},{"key":"269_CR205","doi-asserted-by":"publisher","unstructured":"Alonso-Castro L, de las Heras E, Moreno C, Fleta-Asin B, Munoz-Zato E, Carrillo R et al. Eosinophilic fasciitis\/generalized morphea overlap successfully treated with azathioprine. Int J Dermatol. 2014;53(11):1386\u20138. doi: 10.1111\/j.1365-4632.2012.05741.x .","DOI":"10.1111\/j.1365-4632.2012.05741.x"},{"issue":"4","key":"269_CR206","first-page":"750","volume":"20","author":"AC Jones","year":"1993","unstructured":"Jones AC, Doherty M. Eosinophilic fasciitis with late onset arthritis responsive to sulfasalazine. J Rheumatol. 1993;20(4):750\u20131.","journal-title":"J Rheumatol."},{"issue":"6","key":"269_CR207","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1007\/s10067-005-1099-4","volume":"24","author":"A Bukiej","year":"2005","unstructured":"Bukiej A, Dropinski J, Dyduch G, Szczeklik A. Eosinophilic fasciitis successfully treated with cyclosporine. Clin Rheumatol. 2005;24(6):634\u20136. doi: 10.1007\/s10067-005-1099-4 .","journal-title":"Clin Rheumatol"},{"issue":"3","key":"269_CR208","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/BF02032344","volume":"3","author":"JM Jonge-Bok De","year":"1984","unstructured":"De Jonge-Bok JM, Steven MM, Eulderink F, Cats A. Diffuse (eosinophilic) fasciitis. A series of six cases. Clin Rheumatol. 1984;3(3):365\u201373.","journal-title":"Clin Rheumatol"},{"issue":"1","key":"269_CR209","first-page":"65","volume":"24","author":"M Scheinberg","year":"2006","unstructured":"Scheinberg M, Hamerschlak N, Kutner JM, Ribeiro AA, Ferreira E, Goldenberg J, et al. Rituximab in refractory autoimmune diseases: Brazilian experience with 29 patients (2002\u20132004). Clin Exp Rheumatol. 2006;24(1):65\u20139.","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"269_CR210","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.jbspin.2015.02.008","volume":"82","author":"F Espinoza","year":"2015","unstructured":"Espinoza F, Jorgensen C, Pers YM. Efficacy of tocilizumab in the treatment of eosinophilic fasciitis: report of one case. Jt Bone Spine Revue Rhum. 2015;82(6):460\u20131. doi: 10.1016\/j.jbspin.2015.02.008 .","journal-title":"Jt Bone Spine Revue Rhum"},{"issue":"4","key":"269_CR211","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1001\/jamadermatol.2016.0048","volume":"152","author":"VS Oza","year":"2016","unstructured":"Oza VS, Walsh R, North J, Berger TG, Murase JE. Treatment of eosinophilic fasciitis with sirolimus. JAMA Dermatol. 2016;152(4):488\u201390. doi: 10.1001\/jamadermatol.2016.0048 .","journal-title":"JAMA Dermatol"},{"issue":"4","key":"269_CR212","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1046\/j.1365-2133.2000.03431.x","volume":"142","author":"R Schiener","year":"2000","unstructured":"Schiener R, Behrens-Williams SC, Gottlober P, Pillekamp H, Peter RU, Kerscher M. Eosinophilic fasciitis treated with psoralen-ultraviolet A bath photochemotherapy. Br J Dermatol. 2000;142(4):804\u20137.","journal-title":"Br J Dermatol"},{"issue":"5","key":"269_CR213","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.jbspin.2009.06.001","volume":"76","author":"S Pimenta","year":"2009","unstructured":"Pimenta S, Bernardes M, Bernardo A, Brito I, Castro L, Simoes-Ventura F. Intravenous immune globulins to treat eosinophilic fasciitis: a case report. Jt Bone Spine Revue Rhum. 2009;76(5):572\u20134. doi: 10.1016\/j.jbspin.2009.06.001 .","journal-title":"Jt Bone Spine Revue Rhum"},{"issue":"6","key":"269_CR214","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/sj.bmt.1701137","volume":"21","author":"P Cetkovsky","year":"1998","unstructured":"Cetkovsky P, Koza V, Cetkovska P, Svojgrova M. Successful treatment of severe Shulman\u2019s syndrome by allogeneic bone marrow transplantation. Bone Marrow Transplant. 1998;21(6):637\u20139. doi: 10.1038\/sj.bmt.1701137 .","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"269_CR215","first-page":"131","volume":"28","author":"SW Kim","year":"1997","unstructured":"Kim SW, Rice L, Champlin R, Udden MM. Aplastic anemia in eosinophilic fasciitis: responses to immunosuppression and marrow transplantation. Haematologia. 1997;28(3):131\u20137.","journal-title":"Haematologia."},{"issue":"5","key":"269_CR216","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1097\/00006534-197905000-00031","volume":"63","author":"RL Bang","year":"1979","unstructured":"Bang RL. Case report: use of skin grafting to keep a scleroderma patient ambulant. Plast Reconstr Surg. 1979;63(5):732\u20134.","journal-title":"Plast Reconstr Surg"},{"issue":"3","key":"269_CR217","doi-asserted-by":"publisher","first-page":"e263","DOI":"10.1097\/SCS.0b013e31824ef7e8","volume":"23","author":"G Consorti","year":"2012","unstructured":"Consorti G, Tieghi R, Clauser LC. Frontal linear scleroderma: long-term result in volumetric restoration of the fronto-orbital area by structural fat grafting. J Craniofac Surg. 2012;23(3):e263\u20135. doi: 10.1097\/SCS.0b013e31824ef7e8 .","journal-title":"J Craniofac Surg."},{"issue":"1","key":"269_CR218","first-page":"74","volume":"13","author":"KS Ibler","year":"2015","unstructured":"Ibler KS, Gramkow C, Siemssen PA. Autologous fat transplantation for the treatment of linear scleroderma en coup de sabre. Skinmed. 2015;13(1):74\u20136.","journal-title":"Skinmed."},{"issue":"2","key":"269_CR219","doi-asserted-by":"publisher","first-page":"e103","DOI":"10.1097\/SCS.0b013e3182418ce8","volume":"23","author":"MV Karaaltin","year":"2012","unstructured":"Karaaltin MV, Akpinar AC, Baghaki S, Akpinar F. Treatment of \u201cen coup de sabre\u201d deformity with adipose-derived regenerative cell-enriched fat graft. J Craniofac Surg. 2012;23(2):e103\u20135. doi: 10.1097\/SCS.0b013e3182418ce8 .","journal-title":"J Craniofac Surg."},{"issue":"6 Suppl 1","key":"269_CR220","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1590\/abd1806-4841.20132115","volume":"88","author":"TP Zanelato","year":"2013","unstructured":"Zanelato TP, Marquesini G, Colpas PT, Magalhaes RF, Moraes AM. Implantation of autologous fat globules in localized scleroderma and idiopathic lipoatrophy\u2014report of five patients. Anais Bras Dermatol. 2013;88(6 Suppl 1):120\u20133. doi: 10.1590\/abd1806-4841.20132115 .","journal-title":"Anais Bras Dermatol."},{"issue":"6","key":"269_CR221","doi-asserted-by":"publisher","first-page":"775","DOI":"10.4103\/0378-6323.102398","volume":"78","author":"SP Deshmukh","year":"2012","unstructured":"Deshmukh SP, Dogra BB, Sharma YK, Deo KS. Autologus fat transfer for restoration of facial contour in \u201cprogressive facial hemiatrophy\u201d. Indian J dermatol Venereol Leprol. 2012;78(6):775. doi: 10.4103\/0378-6323.102398 .","journal-title":"Indian J dermatol Venereol Leprol"},{"issue":"5","key":"269_CR222","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1111\/pde.12169","volume":"30","author":"MZ Handler","year":"2013","unstructured":"Handler MZ, Wulkan AJ, Stricker SJ, Schachner LA. Linear morphea and leg length discrepancy: treatment with a leg-lengthening procedure. Pediatr Dermatol. 2013;30(5):616\u20138. doi: 10.1111\/pde.12169 .","journal-title":"Pediatr Dermatol"}],"container-title":["American Journal of Clinical Dermatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40257-017-0269-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-017-0269-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-017-0269-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T17:25:16Z","timestamp":1692725116000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40257-017-0269-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,16]]},"references-count":222,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["269"],"URL":"https:\/\/doi.org\/10.1007\/s40257-017-0269-x","relation":{},"ISSN":["1175-0561","1179-1888"],"issn-type":[{"value":"1175-0561","type":"print"},{"value":"1179-1888","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,16]]}}}